Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine-Based Chemoradiation and TNP-470 for Locally Advanced Pancreatic Cancer
NCT00038701Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 1999
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TNP-470 in pancreatic adenocarcinoma (PDAC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 1999; status: terminated.
02
Drugs
TNP-470
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00038701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038701.